
A Ghanaian lab's guardrail-free drug AI happily designed ricin lookalikes. Nobody made them, thankfully.
Ourtake
Asked to design toxins, the model obliged. The open question is whether DNA synthesis screening would have caught the designs.
What happened
Researchers at MinoHealth AI Labs in Accra, Ghana, removed the guardrails on their drug discovery model, Moremi Bio, in 2024 and asked it to design toxins. It produced designs for 1,020 proteins and 5,000 small molecules, which toxicity-prediction software scored as likely toxic; none were made in a lab. The study was posted to arXiv in May 2025 and has prompted calls to regulate DNA synthesis providers.